147 related articles for article (PubMed ID: 12082477)
1. Glyburide compared to insulin for the treatment of gestational diabetes mellitus: a cost analysis.
Goetzl L; Wilkins I
J Perinatol; 2002; 22(5):403-6. PubMed ID: 12082477
[TBL] [Abstract][Full Text] [Related]
2. Undiagnosed asymptomatic hypoglycemia: diet, insulin, and glyburide for gestational diabetic pregnancy.
Yogev Y; Ben-Haroush A; Chen R; Rosenn B; Hod M; Langer O
Obstet Gynecol; 2004 Jul; 104(1):88-93. PubMed ID: 15229005
[TBL] [Abstract][Full Text] [Related]
3. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization.
Jacobson GF; Ramos GA; Ching JY; Kirby RS; Ferrara A; Field DR
Am J Obstet Gynecol; 2005 Jul; 193(1):118-24. PubMed ID: 16021069
[TBL] [Abstract][Full Text] [Related]
4. Comparison of glyburide and insulin for the management of gestational diabetics with markedly elevated oral glucose challenge test and fasting hyperglycemia.
Ramos GA; Jacobson GF; Kirby RS; Ching JY; Field DR
J Perinatol; 2007 May; 27(5):262-7. PubMed ID: 17363911
[TBL] [Abstract][Full Text] [Related]
5. [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study].
von Ferber L; Köster I; Hauner H
Med Klin (Munich); 2006 May; 101(5):384-93. PubMed ID: 16685485
[TBL] [Abstract][Full Text] [Related]
6. A pharmacoeconomical model for choice of a treatment for pregnant women with gestational diabetes.
Todorova K; Palaveev O; Petkova VB; Stefanova M; Dimitrova Z
Acta Diabetol; 2007 Sep; 44(3):144-8. PubMed ID: 17721753
[TBL] [Abstract][Full Text] [Related]
7. Predictors of glyburide failure in the treatment of gestational diabetes.
Kahn BF; Davies JK; Lynch AM; Reynolds RM; Barbour LA
Obstet Gynecol; 2006 Jun; 107(6):1303-9. PubMed ID: 16738156
[TBL] [Abstract][Full Text] [Related]
8. Comparison of glyburide versus insulin in management of gestational diabetes mellitus.
Ogunyemi D; Jesse M; Davidson M
Endocr Pract; 2007; 13(4):427-8. PubMed ID: 17669723
[No Abstract] [Full Text] [Related]
9. Glyburide for the treatment of gestational diabetes. A critical appraisal.
Moore TR
Diabetes Care; 2007 Jul; 30 Suppl 2():S209-13. PubMed ID: 17596474
[TBL] [Abstract][Full Text] [Related]
10. Resource utilisation and costs in patients with type 2 diabetes mellitus treated with insulin glargine or conventional basal insulin under real-world conditions in Germany: LIVE-SPP study.
Schöffski O; Breitscheidel L; Benter U; Dippel FW; Müller M; Volk M; Pfohl M
J Med Econ; 2008; 11(4):695-712. PubMed ID: 19450076
[TBL] [Abstract][Full Text] [Related]
11. Use of glyburide for the treatment of gestational diabetes: the San Antonio experience.
Conway DL; Gonzales O; Skiver D
J Matern Fetal Neonatal Med; 2004 Jan; 15(1):51-5. PubMed ID: 15101612
[TBL] [Abstract][Full Text] [Related]
12. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
[TBL] [Abstract][Full Text] [Related]
13. Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome.
Langer O; Yogev Y; Xenakis EM; Rosenn B
Am J Obstet Gynecol; 2005 Jan; 192(1):134-9. PubMed ID: 15672015
[TBL] [Abstract][Full Text] [Related]
14. Perinatal outcomes and the use of oral hypoglycemic agents.
Bertini AM; Silva JC; Taborda W; Becker F; Lemos Bebber FR; Zucco Viesi JM; Aquim G; Engel Ribeiro T
J Perinat Med; 2005; 33(6):519-23. PubMed ID: 16318615
[TBL] [Abstract][Full Text] [Related]
15. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
[TBL] [Abstract][Full Text] [Related]
16. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization.
Rand L; Caughey AB
Am J Obstet Gynecol; 2006 Aug; 195(2):628-9; author reply 629-30. PubMed ID: 16579949
[No Abstract] [Full Text] [Related]
17. [Oral blood glucose-lowering medication as a monotherapy in gestational diabetes: a hotly debated topic].
de Valk HW
Ned Tijdschr Geneeskd; 2009; 153():A330. PubMed ID: 19785815
[TBL] [Abstract][Full Text] [Related]
18. The glyburide report card.
Rosenn BM
J Matern Fetal Neonatal Med; 2010 Mar; 23(3):219-23. PubMed ID: 20148742
[TBL] [Abstract][Full Text] [Related]
19. Glyburide as treatment option for gestational diabetes mellitus.
Tempe A; Mayanglambam RD
J Obstet Gynaecol Res; 2013 Jun; 39(6):1147-52. PubMed ID: 23718748
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of switching to biphasic insulin aspart in poorly-controlled type 2 diabetes patients in China.
Palmer JL; Gibbs M; Scheijbeler HW; Kotchie RW; Nielsen S; White J; Valentine WJ
Adv Ther; 2008 Aug; 25(8):752-74. PubMed ID: 18704282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
